Woojung Bio (XKRX:215380) Asset Impairment Charge : ₩0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Woojung Bio Asset Impairment Charge?

Woojung Bio's Asset Impairment Charge for the three months ended in Dec. 2023 was ₩0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was ₩0 Mil.

Woojung Bio Asset Impairment Charge Historical Data

The historical data trend for Woojung Bio's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Woojung Bio Asset Impairment Charge Chart

Woojung Bio Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

Woojung Bio Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Woojung Bio Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

Woojung Bio Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Woojung Bio's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Woojung Bio (XKRX:215380) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Woojung Bio Inc (XKRX:215380) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gwanggyo-ro 145, B-dong 3rd Floor, Next Generation Convergence Technology Research Center, Gyeonggi-do, Yeongtong-gu, Suwon-si, KOR

Website

http://bio.woojungbsc.co.kr

Woojung Bio Inc is engaged in the research and development of natural science and engineering. Its products include Gene Delivery, Antibody Production, Immunodeficiency model, Human-to-human model, Zika, Mers, Dengue, Influenza Virus Research, Influenza virus, vaccine studies, and Elegant Goettingen Mini Pig.

Woojung Bio (XKRX:215380) Headlines

No Headlines